Graeme Alexander

17.0k total citations · 5 hit papers
191 papers, 11.9k citations indexed

About

Graeme Alexander is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Graeme Alexander has authored 191 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Epidemiology, 133 papers in Hepatology and 28 papers in Surgery. Recurrent topics in Graeme Alexander's work include Hepatitis C virus research (91 papers), Hepatitis B Virus Studies (90 papers) and Liver Disease Diagnosis and Treatment (87 papers). Graeme Alexander is often cited by papers focused on Hepatitis C virus research (91 papers), Hepatitis B Virus Studies (90 papers) and Liver Disease Diagnosis and Treatment (87 papers). Graeme Alexander collaborates with scholars based in United Kingdom, United States and Portugal. Graeme Alexander's co-authors include Roger Williams, A L Eddleston, Salim I. Khakoo, Susan E. Davies, David L. Thomas, Chloe L. Thio, Mary Carrington, James J. Goedert, Maureen P. Martin and Didier Samuel and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Graeme Alexander

190 papers receiving 11.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

2009 1.6k citations Graeme Alexander et al. profile →
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection

2004 906 citations Graeme Alexander et al. profile →
Liver Transplantation in European Patients with the Hepatitis B Surface Antigen

1993 785 citations Graeme Alexander et al. profile →
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells

2011 472 citations Graeme Alexander, David A. Lomas et al. profile →
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

2014 454 citations Dina Tiniakos, Michael Allison et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Graeme Alexander	7.2k	7.2k	1.8k	1.6k	1.3k	191	11.9k
Hirohito Tsubouchi	5.7k 0.8×	4.4k 0.6×	1.2k 0.7×	2.9k 1.8×	2.1k 1.5×	319	10.5k
Takeshi Okanoue	6.2k 0.9×	8.7k 1.2×	1.0k 0.6×	2.3k 1.4×	3.9k 2.9×	390	15.5k
Norifumi Kawada	5.0k 0.7×	5.3k 0.7×	1.1k 0.6×	1.8k 1.1×	3.3k 2.4×	371	11.3k
Morikazu Onji	3.6k 0.5×	4.0k 0.6×	1.4k 0.8×	1.1k 0.7×	761 0.6×	313	7.3k
Michio Sata	7.1k 1.0×	6.8k 1.0×	1.2k 0.7×	2.6k 1.6×	3.1k 2.3×	457	15.1k
Jay H. Lefkowitch	4.4k 0.6×	4.9k 0.7×	524 0.3×	1.4k 0.9×	1.6k 1.2×	141	8.6k
Peter J. Scheuer	10.4k 1.5×	9.8k 1.4×	685 0.4×	2.6k 1.6×	1.1k 0.8×	144	14.9k
Eiji Tanaka	7.9k 1.1×	7.7k 1.1×	614 0.3×	1.7k 1.1×	1.1k 0.8×	280	11.2k
Bernard Portmann	9.3k 1.3×	8.1k 1.1×	740 0.4×	4.8k 3.0×	946 0.7×	232	14.6k
Tom H. Karlsen	4.9k 0.7×	3.5k 0.5×	1.1k 0.6×	3.5k 2.2×	1.8k 1.3×	170	9.5k

Countries citing papers authored by Graeme Alexander

Since Specialization

Citations

This map shows the geographic impact of Graeme Alexander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme Alexander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme Alexander more than expected).

Fields of papers citing papers by Graeme Alexander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme Alexander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme Alexander. The network helps show where Graeme Alexander may publish in the future.

Co-authorship network of co-authors of Graeme Alexander

This figure shows the co-authorship network connecting the top 25 collaborators of Graeme Alexander. A scholar is included among the top collaborators of Graeme Alexander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graeme Alexander. Graeme Alexander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cullen, Katherine, Mari Jones, Rhys Pockett, et al.. (2023). Cost of hepatocellular carcinoma to the national health service in England: a registry-based analysis. BMJ Open Gastroenterology. 10(1). e000998–e000998. 3 indexed citations

Fatourou, Evangelia, Dominic King, Martine Walmsley, et al.. (2021). PMO-35 UK national audit on diagnosis and management of colitis in patients with primary sclerosing cholangitis. A94.2–A95. 1 indexed citations

Beebeejaun, Kazim, Zahin Amin‐Chowdhury, Louise Letley, et al.. (2020). Impact of a nurse‐led enhanced monitoring, management and contact tracing intervention for chronic hepatitis B in England, 2015‐2017. Journal of Viral Hepatitis. 28(1). 72–79. 6 indexed citations

Hirschfield, Gideon M., Jessica Dyson, Graeme Alexander, et al.. (2018). The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut. 67(9). 1568–1594. 202 indexed citations

Kim, Jin Un, Vijay P.B. Grover, Louise Southern, et al.. (2017). Early Primary Biliary Cholangitis is Characterised by Brain Abnormalities on Cerebral Magnetic Resonance Imaging. Journal of Clinical and Experimental Hepatology. 7. S28–S29. 1 indexed citations

Low, Gavin, Graeme Alexander, & David J. Lomas. (2015). Hepatorenal Syndrome: Aetiology, Diagnosis, and Treatment. Gastroenterology Research and Practice. 2015. 1–11. 30 indexed citations

Dawwas, Muhammad F., Susan E. Davies, William J. Griffiths, David A. Lomas, & Graeme Alexander. (2012). Prevalence and Risk Factors for Liver Involvement in Individuals with PiZZ-related Lung Disease. American Journal of Respiratory and Critical Care Medicine. 187(5). 502–508. 39 indexed citations

Srivastava, Brijesh & Graeme Alexander. (2011). Renal failure in chronic liver disease and the hepatorenal syndrome. British Journal of Hospital Medicine. 72(9). 497–503. 3 indexed citations

Sen, Sambit & Graeme Alexander. (2009). Pulmonary complications in liver disease. British Journal of Hospital Medicine. 70(12). 685–691. 1 indexed citations

10.

Hoare, Matthew, William Gelson, Simon Rushbrook, et al.. (2008). Histological changes in HCV antibody–positive, HCV RNA–negative subjects suggest persistent virus infection. Hepatology. 48(6). 1737–1745. 33 indexed citations

11.

Rushbrook, Simon, Matthew Hoare, & Graeme Alexander. (2007). T-regulatory lymphocytes and chronic viral hepatitis. Expert Opinion on Biological Therapy. 7(11). 1689–1703. 22 indexed citations

12.

Nash, Kathryn, Michael Allison, Damian McKeon, et al.. (2007). A single centre experience of liver disease in adults with cystic fibrosis 1995–2006. Journal of Cystic Fibrosis. 7(3). 252–257. 48 indexed citations

13.

Hoare, Matthew, et al.. (2005). Case Report: Bell's Palsy Associated with IFN-α and Ribavirin Therapy for Hepatitis C Virus Infection. Journal of Interferon & Cytokine Research. 25(3). 174–176. 16 indexed citations

14.

Jones, Tim D., B.J. Smith, Charles T. Heise, et al.. (2004). The Development of a Modified Human IFN-α2b Linked to the Fc Portion of Human IgG1 as a Novel Potential Therapeutic for the Treatment of Hepatitis C Virus Infection. Journal of Interferon & Cytokine Research. 24(9). 560–572. 32 indexed citations

15.

McKeon, Damian, Anthony I. Day, J. Parmar, Graeme Alexander, & Diana Bilton. (2004). Hepatocellular carcinoma in association with cirrhosis in a patient with cystic fibrosis. Journal of Cystic Fibrosis. 3(3). 193–195. 19 indexed citations

16.

Alexander, Graeme, et al.. (2000). CHRONIC VIRAL HEPATITIS. International Journal of Clinical Practice. 54(7). 450–456. 5 indexed citations

17.

Petrík, Juraj, et al.. (1998). Hepatic histology in hepatitis C virus carriers coinfected with hepatitis G virus. Gut. 42(1). 103–106. 22 indexed citations

18.

Lau, Johnson Y. N., C. J. Tibbs, A. Catterall, et al.. (1993). Loss of HBsAg with interferon‐α therapy in chronic hepatitis D virus infection. Journal of Medical Virology. 39(4). 292–296. 23 indexed citations

19.

Bird, George, et al.. (1989). CONTRASTS IN INTERLEUKIN-1 AND INTERLEUKIN-2 ACTIVITY IN ALCOHOLIC HEPATITIS AND CIRRHOSIS. Alcohol and Alcoholism. 24(6). 541–546. 7 indexed citations

20.

Alexander, Graeme & R. Williams. (1986). Antiviral treatment in chronic infection with hepatitis B virus.. BMJ. 292(6525). 915–917. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact